SKI Market

Indian Indices

Sensex

84,941.03 -122.31
( -0.14%)

Global Indices

Nasdaq

49,481.66 483.47
(0.99%)

Dow Jones

6,965.42 42.37
(0.61%)

Hang Seng

52,499.37 666.57
(1.29%)

Nikkei 225

10,156.61 152.04
(1.52%)

Forex

USD-INR

90.21 0.17
(0.19%)

EUR-INR

105.52 0.01
(0.01%)

GBP-INR

121.54 0.38
(0.31%)

JPY-INR

0.58 0.00
(0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5600262

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.78

123617.27

EPS(TTM)

Face Value()

Div & Yield %

64.35

1.05

Back

Suryoday Small Finance Bank standalone net profit declines 33.00% in the September 2025 quarter

Nov 07,2025

Net profit of Suryoday Small Finance Bank declined 33.00% to Rs 30.41 crore in the quarter ended September 2025 as against Rs 45.39 crore during the previous quarter ended September 2024. Total Operating Income rose 2.46% to Rs 519.66 crore in the quarter ended September 2025 as against Rs 507.20 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Total Operating Income	519.66	507.20	2
OPM %	42.51	43.36	-
PBDT	39.30	60.15	-35
PBT	39.30	60.15	-35
NP	30.41	45.39	-33

84,941.03 -122.31 ( -0.14%)

49,481.66 483.47 (0.99%)

6,965.42 42.37 (0.61%)

52,499.37 666.57 (1.29%)

10,156.61 152.04 (1.52%)

90.21 0.17 (0.19%)

105.52 0.01 (0.01%)

121.54 0.38 (0.31%)

0.58 0.00 (0.26%)